Home › Funds › RTW INVESTMENTS, LP › IMVT
RTW INVESTMENTS, LP position in IMVT
IMMUNOVANT INC · Health Care
RTW INVESTMENTS, LP reported holding 3,177,849 shares of IMVT (IMMUNOVANT INC) in its Q2 2026 13F filing — a position valued at US$122.4M, representing 1.05% of its reported portfolio and ranking #32 among its reported holdings. RTW INVESTMENTS, LP has disclosed IMVT holdings in 4 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How RTW INVESTMENTS, LP's IMVT position evolved
RTW INVESTMENTS, LP first disclosed a stake in IMVT in Q4 2024 at 530,614 shares (US$13.1M). The position peaked in Q2 2026 at 3,177,849 shares, worth US$122.4M. Across 4 filings, RTW INVESTMENTS, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 3,177,849 shares valued at US$122.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 530.61K | $13.14M | New |
| Q4 2025 | 3.18M | $80.78M | New |
| Q1 2026 | 3.18M | $78.94M | Hold |
| Q2 2026 | 3.18M | $122.44M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMVT and 13F data
IMVT (IMMUNOVANT INC) is a Health Care company. 39 other funds we track also report a position in IMVT — the largest reported positions include Deep Track Capital, LP (US$359.9M), Farallon Capital Management (US$223.7M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$223.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMVT
- Deep Track Capital, LP 9.34M sh · $359.91M · Q2 2026
- Farallon Capital Management 5.80M sh · $223.67M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 5.80M sh · $223.67M · Q2 2026
- BAKER BROS. ADVISORS LP 5.44M sh · $209.42M · Q2 2026
- TCG Crossover Management, LLC 4.46M sh · $171.77M · Q2 2026
- Two Seas Capital LP 4.61M sh · $155.82M · Q3 2026
- ADAR1 Capital Management, LLC 2.33M sh · $89.80M · Q2 2026
- Alpine Global Management, LLC 1.38M sh · $52.98M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.36M sh · $52.30M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.20M sh · $46.24M · Q2 2026
- Logos Global Management LP 665.00K sh · $25.62M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 619.10K sh · $23.85M · Q2 2026
More on RTW INVESTMENTS, LP
FAQ
How long has RTW INVESTMENTS, LP held IMVT?
RTW INVESTMENTS, LP has disclosed IMVT holdings in 4 of the last 7 reported quarters, going back to Q4 2024.
What is RTW INVESTMENTS, LP's current position in IMVT?
As of Q2 2026, RTW INVESTMENTS, LP holds 3.18M shares of IMVT (IMMUNOVANT INC), valued at $122.44M, representing 1.05% of its reported portfolio and ranking #32.
Has RTW INVESTMENTS, LP been buying or selling IMVT?
In the latest 13F filing (Q2 2026), RTW INVESTMENTS, LP held unchanged its position in IMVT. The position peaked in Q2 2026 at 3.18M shares.
Which other funds hold IMVT?
Other major institutional holders of IMVT include Deep Track Capital, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.